Figure 1

Clinical study design. Blood samples for the number of CD34⁺ cells ([CD34⁺]) / CD34⁺CD38^– cells ([CD34⁺CD38^–]) at 06:00 hours were drawn immediately prior to granulocyte colony-stimulating factor (G-CSF) administration on days 4 and 5. PB, peripheral blood.